Evidence map›Paper›PMID 38717041›Full record

SynthesisThe Journal of international medical research2024

Understanding Creutzfeldt-Jakob disease in Iran: a systematic review of case reports.

Alireza Mohebbi, Parastoo Motamedaria, Malihe Naderi, Mina Hassanpour, Zahra Salavatiha, Mahsa Makouei, Angila Ataei-Pirkooh

Abstract readSystematic Review
In one paragraph

Synthesis in The Journal of international medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alireza MohebbiDepartment of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-2662-8659
Parastoo MotamedariaDepartment of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Malihe NaderiDepartment of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
Mina HassanpourDepartment of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran.
Zahra SalavatihaDepartment of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mahsa MakoueiSchool of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Angila Ataei-PirkoohDepartment of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo systematically review the reported cases of Creutzfeldt-Jakob disease (CJD) in Iran.

methodsA comprehensive literature review of CJD cases in Iran was undertaken using the PubMed®, Scopus® and Google Scholar databases. In addition, the Iranian database MagIran was searched for Persian language reports. Case selection used the following criteria: (i) patients of Iranian origin; (ii) publication in peer-reviewed journals or reputable medical databases; (iii) a definitive diagnosis of CJD based on established diagnostic criteria.

resultsThirteen cases from twelve reports were included in this systematic review. The majority of the cases were female (11 of 13; 84.6%). The mean ± SD age of patients at hospital admission was 59.38 ± 7.44 years. The findings of the case review suggested that the prevalence of CJD in Iran is not fully established. CJD may be misdiagnosed alongside other clinical signs. The most prevalent early indications of the disease were psychiatric and neurological in nature. A considerable delay in diagnosis was observed in some cases and there was a shortage of brain autopsy records.

conclusionEfforts to improve diagnostic capabilities, promote awareness and establish monitoring systems are necessary for managing the challenges of providing an early diagnosis of CJD in Iran.

Indexed as

Creutzfeldt-Jakob SyndromeAgedBrainFemaleHumansIranMaleMiddle AgedPrevalencecase reportsclinical characteristicsCreutzfeldt-Jakob diseaseneurodegenerative diseasesprion diseases

Identifiers

PMID38717041
PMCPMC11080748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.